ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2026
Identification of a Tenochondral Ossification Sequence Producing Heterotopic Ossification in Human Achilles Tendinopathy.
Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Achilles tendinopathy is a common musculoskeletal disorder. A frequent late-stage manifestation is tendon heterotopic ossification (HO). Achilles HO forms predominantly via endochondral ossification, yet the cellular and molecular mechanisms underlying this pathologic condition remain elusive. Here, we analyzed surgically excised biopsy samples with symptomatic human Achilles tendons alongside non-diseased Achilles tendon controls primarily from lower-limb amputation donors to characterize the morphologic and mineralization patterns of the disease. Based on these analyses, we propose a stepwise endochondral model of Achilles HO that we term "tenochondral ossification" to emphasize the chondrogenic intermediate stage and its tendon origin. This process includes tendon-to-cartilage metaplasia, characterized by increased glycosaminoglycan content (Alcian blue-positive matrix) and the appearance of chondrocyte-like cells aligning the collagen fibers; some cells have substantial RUNX2 or SOX9 expression; subsequent mineralization of the metaplastic tissue, indicated by alkaline phosphatase immunoreactivity and neovessel ingrowth; osteoclast differentiation and resorption of the calcified metaplastic tissue; and new bone deposition on metaplastic tendon remnants accompanied by robust RUNX2 immunoactivity. Furthermore, TNC expression remains high in the metaplastic cartilage but diminishes at the mineralization front. Taken together, these data support a tendon-origin, endochondral pathway for Achilles tendon HO and highlight stage-specific therapeutic opportunities for treating or preventing Achilles tendinopathy and HO development and progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.